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LETTERS
Spelling 
Pneumocystis 
jirovecii
To the Editor: Our 2002 ar-
ticle in Emerging Infectious Dis-
eases about nomenclature changes 
for organisms in the genus Pneumo-
cystis (1) has been widely cited and 
probably will remain a source for 
persons seeking information about 
this subject. Therefore, we need to 
correct an error in 1 of the species 
names presented in our article and 
in the 1999 article by Frenkel (2) on 
which our article was based. In the 
1999 article, Frenkel proposed that 
the species of Pneumocystis found in 
humans be named to honor the Czech 
parasitologist, Otto Jirovec. The 1999 
article was his second proposal for 
this change. In 1976, he fi rst named 
the human pathogen Pneumocystis 
jiroveci (3), at which time it was clas-
sifi ed as a protozoan and therefore 
named according to the International 
Code of Zoological Nomenclature. 
By 1999, it had become clear that the 
organisms in the genus Pneumocystis 
are fungi, which are named according 
to the International Code of Botanical 
Nomenclature (ICBN) (4). Differenc-
es between the International Code of 
Zoological Nomenclature and ICBN 
resulted in the realization of an er-
ror in the species epithet proposed 
by Frenkel in 1999, and our 2002 
article contained this error. Frenkel’s 
1999 article should have modifi ed 
the species epithet from “jiroveci” to 
“jirovecii,” (ICBN Articles 32.7 and 
60.11 and Rec. 60C.1b). The correct 
and valid name under ICBN is Pneu-
mocystis jirovecii. Redhead et al. fur-
ther explain the basis for this correc-
tion (5).
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Hypothetical 
Pneumocystis 
jirovecii 
Transmission from 
Immunocompetent 
Carriers to Infant
To the Editor: The recent dis-
patch article by Rivero et al. reports 
the transmission of Pneumocystis 
jirovecii from immunocompetent 
grandparents to their granddaugh-
ter (1). The authors’ conclusion was 
based on 2 facts: the grandparents 
were carriers but neither the parents 
nor the child’s brother was a carrier, 
and the P. jirovecii genotype observed 
in the grandparents was identical to 
that found in the infant. In our opin-
ion, the data provided by the authors 
do not support the conclusion that 
transmission has occurred. First, the 2 
markers used for typing show a small 
number of alleles and thus provide 
low discrimination among isolates (2). 
Consequently, the P. jirovecii isolates 
present in the grandparents and in the 
infant may have been epidemiologi-
cally unrelated. Second, the frequency 
of occurrence of the different geno-
types obtained was not investigated. 
The presence of the same genotype 
in the grandparents and in the infant 
may result from a high frequency of 
this genotype in the geographic area 
where the family lived. In fact, the use 
of a validated typing method and the 
analysis of unlinked control patients 
have proven necessary in other stud-
ies to demonstrate transmission of P. 
jirovecii (3–7). We believe that the 
reported transmission event remains a 
hypothesis.
Philippe Hauser, 
Meja Rabodonirina, 
and Gilles Nevez
Author affi liations: Centre Hospitalier Uni-
versitaire Vaudois and University of Lau-
sanne, Lausanne, Switzerland (P. Hauser); 
Université Claude-Bernard, Hospices Civils 
506 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 3, March 2009
Letters
Letters commenting on recent articles 
as well as letters reporting cases, out-
breaks, or original research are wel-
come. Letters commenting on articles 
should contain no more than 300 
words and 5 references; they are more 
likely to be published if submitted 
within 4 weeks of the original article’s 
publication. Letters reporting cases, 
outbreaks, or original research should 
contain no more than 800 words 
and 10 references. They may have 1 
Figure or Table and should not be di-
vided into sections. All letters should 
contain material not previously pub-
lished and include a word count.
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In Response: We appreciate the 
comments from Hauser et al. (1) re-
garding our article that reported a case 
of Pneumocystis jirovecii transmission 
from colonized grandparents to their 
infant granddaughter (2). We agree 
with the authors that the 2 markers 
used for typing, which are described in 
our article, present a small number of 
alleles and thus provide low discrimi-
nation between isolates. However, 
these typing methods have been vali-
dated and have proven useful for mo-
lecular epidemiologic applications in 
P. jirovecii colonization studies (3,4). 
Unfortunately, other typing methods 
that can identify a high number of al-
leles, such as the sequence analysis of 
the internal transcribed spacer no. 1 
and 2 gene regions, could not be used 
in our study because a low amplifi ca-
tion rate has been observed for these 
regions when such methods are used 
to study colonized subjects (5). On 
the other hand, the multitarget single-
strand conformation polymorphism 
method has been used only in patients 
with Pneumocystis pneumonia, and 
its usefulness for epidemiologic stud-
ies in colonized subjects has not been 
proven (6). For our study, we think 
that genotyping analysis of the mtL-
SU rRNA gene together with the di-
hydropteroate synthase (DHPS) gene 
provided suffi cient epidemiologic in-
formation because this strategy allows 
identifi cation of 24 different combi-
nations of genotypes. However, no 
typing method is able to demonstrate 
interhuman P. jirovecii transmission 
conclusively because a common envi-
ronmental source of infection cannot 
be ruled out in any case. Therefore, 
as we noted in our article, “We can-
not exclude the possibility that the 
cases described were infected by the 
same environmental source,” and we 
only hypothesized that “the infant was 
infected by P. jirovecii through close 
contact with her grandparents.” How-
ever, we continue to think that the air-
borne transmission of P. jirovecii from 
the grandfather to the grandmother 
and the infant is the most probable 
explanation based on genotype data. 
Also, all persons in close contact with 
the infant were studied, and only her 
grandparents were colonized by P. 
jirovecii. Future research is needed 
to assess the importance of colonized 
subjects in the P. jirovecii transmis-
sion to susceptible hosts.
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